How FBS is made - Innovative Bioscience FBS bottle centered in pharmaceutical manufacturing facility with filtration equipment and quality control microscope
19 min read

How FBS Is Made: From Collection to Your Lab

In This Article

Fetal bovine serum remains the most widely used supplement in mammalian cell culture, yet surprisingly few researchers understand the manufacturing chain that transforms raw bovine blood into the clear, straw-colored liquid they pipette into their media. That knowledge gap matters. Understanding how FBS is made — from collection through final release — equips you to evaluate suppliers, read Certificates of Analysis critically, and make informed procurement decisions that directly affect your experimental reproducibility. This guide walks through the entire process: collection, processing, filtration, quality control testing, COA interpretation, storage, and the industry standards that govern it all.

Collection: Where FBS Originates

FBS is a byproduct of the beef industry. No animals are raised or slaughtered specifically for serum production. Pregnant cows are identified during routine processing at government-inspected abattoirs — facilities regulated by the USDA in the United States, CFIA in Canada, DAWR in Australia, and equivalent authorities in other producing countries.

FBS collection and processing stages from facility collection through centrifugation to bulk pooling in manufacturing workflow

Once a pregnant cow is identified, the intact uterus is removed and transported to a dedicated, separate collection area within the abattoir. This physical separation from the slaughter floor is critical for maintaining aseptic conditions. The fetus is extracted, and blood is collected only after the fetus is confirmed dead — a requirement aligned with the OIE Terrestrial Animal Health Code Section 7.5 and the Five Freedoms framework for animal welfare.

The Cardiac Puncture Technique

Blood is collected via cardiac puncture: a sterile, large-bore needle is inserted directly into the fetus's heart. The blood flows through a closed collection system into pre-sterilized containers or blood bags, minimizing environmental contamination. This closed-system approach is essential — any microbial introduction at this stage becomes extraordinarily difficult to remove downstream, particularly endotoxins (soluble lipopolysaccharides from gram-negative bacteria), which survive filtration and even autoclaving.

Collection Yields

The volume of blood recovered depends on gestational age:

Gestational Age Approximate Blood Yield
3 months ~150 mL
6 months ~350 mL
Full term (rare) Up to ~500 mL

It takes one to three fetuses to produce a single liter of finished serum after processing losses. This biological reality — combined with the fact that collection depends entirely on the throughput of the beef industry — is why FBS supply can tighten during droughts, herd reductions, or shifts in cattle markets, and why prices fluctuate more than most laboratory reagents.

Processing: From Whole Blood to Raw Serum

The collected blood undergoes a series of processing steps to separate the serum fraction from cellular components, clotting factors, and debris.

Step 1: Clotting

Whole blood is refrigerated immediately after collection and allowed to clot naturally in sterile containers. During clotting, fibrinogen converts to fibrin, trapping red blood cells, white blood cells, and platelets in the clot matrix. The remaining liquid — the serum — separates as a clear, straw-colored supernatant. This is fundamentally different from plasma, which is collected with anticoagulants and retains clotting factors.

Step 2: Centrifugation

The clotted blood is centrifuged at approximately 400×g for 5 minutes. This relatively gentle spin pellets residual cellular material without shearing cells or denaturing proteins. The clear yellow supernatant is carefully transferred to sterile tubes, leaving the clot and packed cells behind.

Step 3: Initial Freezing

Raw serum is frozen for storage and transport to the processing facility. One practical note: residual fibrinogen in the serum may form visible fibrin strands or flocculent material when the serum is later thawed. This is entirely normal and does not affect biological performance. Researchers encountering these precipitates for the first time sometimes mistake them for contamination — they are not.

Step 4: Pooling

Individual collections are combined into production lots through a process called "true pooling." Pooling serves a critical purpose: it normalizes the biological variation inherent in individual animals. A single fetus might produce serum with unusually high hemoglobin (indicating a difficult collection) or atypical growth factor profiles. By pooling dozens to hundreds of individual collections, manufacturers create lots with more consistent performance characteristics. Full traceability is maintained throughout — responsible manufacturers can trace any finished bottle back to the individual 4-liter collection jugs that contributed to that lot.

Step 5: Aseptic Dispensing

Finished serum is dispensed into final containers under cGMP conditions in positive-pressure, HEPA-filtered clean rooms. Bottles are frozen to -20°C and quarantined until the full quality control testing panel is completed and all specifications are met. Only then are lots released for sale.

Filtration: The Primary Sterility Barrier

Filtration is the single most important step for removing microbial contaminants from FBS. The industry standard is triple filtration through 0.1 µm pore-size membranes — notably smaller than the 0.2 µm filters used for many other biological solutions.

FBS bottle in quality control clean room with sterile filtration equipment and QC testing for pharmaceutical-grade manufacturing

What 0.1 µm Filtration Achieves

Triple 0.1 µm filtration achieves a Sterility Assurance Level (SAL) of 10⁻³ and effectively removes:

  • Bacteria — including small species like mycoplasma (though mycoplasma testing remains essential as a verification step)
  • Fungi and mold spores
  • Most viral agents — by size exclusion

What Filtration Cannot Remove

No filtration system removes everything. Two categories of contaminants survive 0.1 µm filtration:

  • Endotoxins — Lipopolysaccharides (LPS) from gram-negative bacterial cell walls are soluble molecules, not particulates. They pass freely through any membrane filter. Endotoxin levels in finished FBS are determined almost entirely by how cleanly the blood was collected. This is why collection technique and facility hygiene matter so much — once endotoxins are in the serum, they cannot be filtered out.
  • Prion proteins — Misfolded proteins associated with transmissible spongiform encephalopathies (BSE/TSE). Prion control relies on sourcing from BSE-negligible-risk countries and maintaining geographic traceability, not on filtration.

One virus deserves special mention: Bovine Viral Diarrhea Virus (BVDV). Due to its small size and pleomorphic nature, BVDV can potentially pass through 0.1 µm filters. This is precisely why additional viral testing — and optionally, gamma irradiation — are critical components of the quality assurance program.

Gamma Irradiation (Optional)

Some applications require an additional level of viral inactivation beyond filtration. Gamma irradiation at 25–40 kGy using a Cobalt-60 source can eliminate up to 6 logs of viral, bacterial, and mycoplasma contaminants. Irradiation can be applied to frozen serum, and properly irradiated FBS retains greater than 80% of its growth promotion activity. Innovative Bioscience offers gamma irradiation as an add-on service for researchers who need this additional assurance.

Quality Control Testing: What Gets Measured and Why

Quality control is where responsible manufacturers separate themselves from commodity suppliers. A premium FBS lot may undergo 50 to 70 individual specification tests before release. Here is the full panel and what each test reveals about the serum in your incubator.

Complete QC Testing Panel

Test Method Specification Why It Matters
Endotoxin LAL Gel-Clot assay <10 EU/mL (standard), ≤5 EU/mL (ultra-low) Endotoxin permanently alters cell behavior, activates immune cells, skews differentiation. One EU/mL corresponds to approximately 0.1–0.2 ng/mL LPS.
Hemoglobin Colorimetric assay ≤25 mg/dL (10–30 mg/dL normal) Elevated hemoglobin indicates hemolysis during collection — delayed processing, rough handling, or premature freezing. Can cause virus release from lysed red blood cells.
Sterility USP <71> / EP 2.6.1 No growth, 14-day incubation Dual media system: TSB at 20–25°C (fungi/mold) and Thioglycolate at 30–35°C (bacteria). Fourteen days is non-negotiable.
Mycoplasma Large Volume Barile Method + PCR Negative (28-day culture) Barile method remains the gold standard: 28-day culture at dual temperatures (36°C and 32°C). PCR provides a rapid complementary screen (hours vs. weeks) but cannot distinguish viable from non-viable organisms.
Virus Panel (9 CFR 113.53) Fluorescent antibody + cytopathicity + hemadsorption Negative for all tested agents Minimum 9 viruses: BVDV, BRSV, IBR, PI3, Bovine Parvovirus, Bluetongue, Rabies, Bovine Adenovirus, Reovirus. BVDV is the most critical — most commercial FBS batches contain pestivirus antibodies, and many test positive by RT-PCR even after irradiation.
pH Potentiometric 6.8–7.8 Basic quality indicator. Values outside range suggest degradation or contamination.
Osmolality Freezing point depression 280–340 mOsm/kg Ensures the serum has not been diluted with water — an adulteration check.
Total Protein Biuret or BCA 3.0–4.5 g/dL FBS has the lowest total protein of all bovine serum types, reflecting the fetal stage of development. Unusually high values may indicate adulteration with adult serum.
IgG Radial immunodiffusion or nephelometry <300 µg/mL Values exceeding 300 µg/mL indicate possible adulteration with newborn or adult bovine serum. True fetal serum has minimal immunoglobulin because the bovine placenta does not transfer maternal antibodies.
GGT Enzymatic kinetic assay <10 IU/L (FBS: 0–5 IU/L) The definitive authenticity marker. Newborn calf serum (NBCS): 160–1,000 IU/L. Any value exceeding 100 IU/L is definitively not fetal bovine serum. This single test catches the most common fraud in the industry.
Growth Promotion Multi-cell-line assay Passes at 2%, 5%, 10%, 20% concentrations Tested on multiple cell lines (commonly MRC-5 and BHK-21), minimum 12 wells per test condition. Premium lots undergo up to 70 individual specification tests. This is the ultimate functional assay.
Electrophoresis Serum protein electrophoresis Characteristic fetal profile Separates alpha-1, alpha-2, beta, and gamma globulin fractions. True FBS shows a characteristically very low gamma fraction — another authenticity indicator that complements GGT and IgG testing.

A Note on Endotoxin Variability

A published study examining 40 FBS lots from 13 different manufacturers found a median endotoxin concentration of 46 ng/mL with extremely wide variation across suppliers. This finding underscores a critical point: endotoxin levels are primarily a function of collection hygiene, not downstream processing. No amount of filtration or treatment can compensate for sloppy collection technique. When evaluating FBS suppliers, endotoxin specifications — and more importantly, actual lot-specific test results — should be near the top of your checklist.

Reading a Certificate of Analysis: What to Look For and What to Question

A Certificate of Analysis is only as useful as your ability to read it critically. Not all COAs are created equal, and some omissions are more telling than what is included.

What a Complete COA Should Include

  1. Lot number (batch-specific, not generic)
  2. Date of manufacture or release
  3. Filtration statement (method and pore size)
  4. Country of collection (where the blood was drawn)
  5. Country of manufacture (where the serum was processed)
  6. Growth promotion results (cell lines, concentrations, pass/fail)
  7. Sterility test results (method, duration, result)
  8. Mycoplasma screening results (method and result)
  9. Viral screening panel (individual virus results)
  10. Endotoxin (method and result with units)
  11. Hemoglobin (with units)
  12. Total protein
  13. IgG concentration
  14. GGT level
  15. pH and osmolality

Eleven Red Flags on a COA

If you encounter any of these on a supplier's COA, ask questions before purchasing:

  1. Missing GGT and IgG values — Without these two tests, there is no objective verification that the product is actually fetal bovine serum rather than cheaper newborn calf serum. This is the single most important red flag.
  2. GGT between 10 and 100 IU/L — Suggests contamination or adulteration with newborn or adult bovine serum and warrants investigation before purchase. Any value above 100 IU/L definitively indicates the product is not fetal bovine serum. True FBS consistently reads 0–5 IU/L.
  3. IgG exceeding 300 µg/mL — Not consistent with true fetal serum. The bovine placenta is syndesmochorial and does not transfer maternal immunoglobulins.
  4. "Test and Report" instead of specifications — This means the manufacturer tests the parameter but sets no pass/fail threshold. A result of 500 EU/mL endotoxin on a "Test and Report" COA technically passes. Demand actual specifications with defined limits.
  5. Missing lot number or only generic batch data — Every bottle should trace to a specific, unique production lot.
  6. No country of origin or vague geographic statements — "Product of multiple origins" or no origin statement at all should prompt further inquiry. Geographic origin affects BSE risk classification and regulatory status.
  7. Endotoxin exceeding 10 EU/mL — For standard-grade FBS, this suggests collection hygiene problems. For sensitive applications, you should be looking for ≤5 EU/mL.
  8. Hemoglobin above 30 mg/dL — Indicates significant hemolysis during collection, which correlates with rougher handling and potentially higher endotoxin.
  9. No laboratory accreditation information — Reputable testing is performed by accredited laboratories. The absence of any accreditation reference is a concern.
  10. Suspiciously perfect round numbers — A hemoglobin result of "0.00 mg/dL" or endotoxin of "0.000 EU/mL" is biologically implausible. Real analytical testing produces trace values. Perfect zeros suggest the COA may not reflect actual testing.
  11. Supplier will not provide batch-specific COAs before purchase — If a supplier requires you to buy first and receive the COA after, they are not confident in their product. Any reputable manufacturer should provide the COA for the specific lot you will receive, prior to your purchase decision.

Verification tip: If you have doubts about a serum's identity, submit a sample for an independent large animal chemistry panel at a veterinary diagnostic laboratory. GGT, IgG, and total protein will conclusively establish whether the product is truly fetal.

Storage, Thawing, and Cold Chain Management

Storage Requirements

  • Temperature: -10°C to -40°C, with -20°C being the most common storage temperature
  • Freezer type: Manual defrost only. Never store FBS in a frost-free (auto-defrost) freezer — the cyclic warming degrades the serum over time
  • Lower limit: Never store below -40°C. At ultra-low temperatures, glass and plastic bottles become brittle and may crack
  • Shelf life: 5 years from date of manufacture when stored at -20°C

Thawing Protocol

  1. Place the frozen bottle in a room-temperature to 37°C water bath
  2. Swirl gently every 10–15 minutes to distribute heat evenly and prevent localized overheating
  3. Never exceed 37°C — excessive heat denatures growth factors and other heat-labile proteins
  4. Once thawed, aliquot into working volumes to avoid repeated freeze-thaw cycles
  5. Thawed serum stored at 2–8°C (refrigerator) is stable for up to 4 weeks

Cold Chain Precipitates

Researchers frequently observe flocculent material, cloudiness, or fibrous strands in thawed FBS. These cold chain precipitates consist primarily of lipoproteins, residual fibrinogen, and vitronectin that come out of solution during the freeze-thaw process. They are normal and do not affect the biological performance of the serum. If they are aesthetically bothersome or if you are concerned about clogging narrow-bore pipette tips, the precipitates can be removed by centrifugation at 400×g for 5 minutes, though this is rarely necessary.

Shipping

FBS must be shipped on dry ice and must maintain a frozen state throughout transit. Any interruption in the cold chain — even a partial thaw and refreeze during shipping — constitutes an uncontrolled freeze-thaw cycle and may affect lot-to-lot consistency in your experiments.

Industry Standards and Regulatory Framework

FBS manufacturing operates under a web of overlapping standards that govern everything from animal welfare during collection to final product release.

Standard Governing Body What It Covers
OIE Terrestrial Animal Health Code, Section 7.5 World Organisation for Animal Health Animal welfare during collection, slaughter procedures, and serum harvesting practices
9 CFR Part 113.53 USDA APHIS Viral testing requirements for bovine-origin biologics — defines the minimum virus panel
USP <71> / EP 2.6.1 US Pharmacopeia / European Pharmacopoeia Sterility testing methodology — dual media, 14-day incubation protocol
cGMP (21 CFR 820) US FDA Current Good Manufacturing Practice — facility requirements, process controls, documentation
ISO 9001:2015 International Organization for Standardization Quality management systems — process documentation, corrective actions, continuous improvement
ISIA Traceability International Serum Industry Association Supply chain traceability, independent audits, geographic origin verification

ISIA and Geographic Verification

The International Serum Industry Association was founded in 2006 to address concerns about traceability and origin fraud in the global serum market. ISIA member companies submit to independent audits and participate in geographic verification programs. One particularly powerful tool is Oritain geographic fingerprinting, which analyzes 35+ trace elements and stable isotope ratios in serum samples to verify the claimed country of collection. This analytical approach can detect origin fraud even when paper documentation appears correct — a capability that has proven necessary given documented cases of origin misrepresentation in the industry.

How Innovative Bioscience Approaches FBS Manufacturing and Quality

We built our FBS program around a straightforward principle: researchers should be able to verify every claim we make about our serum before they spend a dollar. Here is how that principle translates into practice.

Traceability

Our FBS is sourced through our ISIA member supply chain with full traceability from collection to final release, per ISIA standards. Every lot can be traced back through the manufacturing chain to the individual collection facility and geographic origin. We offer FBS across four origin categories — US Origin, USDA Approved, South American, and Australian — so you can select the origin that matches your regulatory requirements or institutional preferences.

Testing Standards

Every lot released by Innovative Bioscience undergoes:

  • Full 9 CFR 113.53 virus panel — all nine required viruses tested by fluorescent antibody, plus cytopathicity and hemadsorption
  • Triple 0.1 µm filtration — industry-standard sterility barrier
  • 14-day USP <71> sterility testing — dual media, no shortcuts
  • Mycoplasma screening — culture-based and PCR complementary methods
  • Published endotoxin specification of ≤5 EU/mL — stricter than the industry-standard <10 EU/mL threshold used by most suppliers
  • Complete authenticity panel — GGT, IgG, total protein, and electrophoretic profile on every lot

Transparency

We publish our pricing on our website — no quote requests required, no hidden institutional markups, no opaque discount structures. Our USDA Approved Origin FBS is $425 per 500 mL and our US Origin FBS is $595 per 500 mL. COAs are available for instant download on every product page. You can review the full testing panel for any lot before placing an order, without calling a sales representative or submitting an email request.

Lot Reservation

Once you identify a lot that performs well in your system, we offer lot reservation so you can secure additional inventory of that specific lot for future experiments. Lot-to-lot variation is an inherent characteristic of any biological product, and locking in a validated lot eliminates a variable from your research.

We carry over 20 FBS products across four geographic origins, plus specialty formulations including heat-inactivated, charcoal-stripped, dialyzed, and exosome-depleted variants. Whether you are running routine cell culture maintenance or optimizing conditions for a sensitive primary cell line, the manufacturing fundamentals described in this guide apply to every bottle on our shelves — and we are happy to walk through any of it with you.

Related Articles